Clinical Trials Logo

Filter by:
NCT ID: NCT06108219 Recruiting - Clinical trials for Nonalcoholic Steatohepatitis (NASH)

A Phase 2b, Study Evaluating Miricorilant in Adult Patients With Nonalcoholic Steatohepatitis/Metabolic Dysfunction-Associated Steatohepatitis (MONARCH)

Start date: October 25, 2023
Phase: Phase 2
Study type: Interventional

A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Miricorilant in Adult Patients with Nonalcoholic Steatohepatitis (MONARCH)

NCT ID: NCT06108206 Recruiting - Glioblastoma Clinical Trials

Adaptive Radiotherapy and MRIs Based on Patients With Newly Diagnosed High-Grade Glioma

Start date: January 30, 2024
Phase: N/A
Study type: Interventional

The purpose of this study is to find out if performing additional Magnetic Resonance Image (MRI) scans of the subjects' brain during each week of the radiation treatment of their high-grade glioma will help improve the radiation treatment.

NCT ID: NCT06108141 Recruiting - Virtual Reality Clinical Trials

Virtual Reality Intervention to Support Clinicians' Firearm Safety Counseling Behaviors

REACH_CCTST
Start date: December 19, 2023
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to assess the efficacy of REACH Firearm Safety in a sample of pediatric residents. The main question it aims to answer are: Do residents who have completed REACH Firearm Safety have increased documentation in the electronic medical records for screening and counseling for safe firearm storage? Participants will be asked to engage in a virtual reality curriculum (REACH Firearm Safety). Researchers will compare the REACH Firearm safety group to a group of participants who complete an abbreviated online training.

NCT ID: NCT06108128 Recruiting - Eating Behavior Clinical Trials

Food for Thought: Executive Functioning Around Eating Among Children

Start date: October 5, 2023
Phase: N/A
Study type: Interventional

Scientific knowledge of the cognitive-developmental processes that serve to support children's appetite self-regulation are surprisingly limited. This investigation will provide new scientific directions for obesity prevention by elucidating cognitive-developmental influences on young children's ability to make healthy food choices and eat in moderation.

NCT ID: NCT06108115 Completed - Sleep Disturbance Clinical Trials

Smartphone-Based Intervention for Sleep Disturbance in Individuals Recovering From Alcohol Use Disorder

Start date: September 13, 2021
Phase: N/A
Study type: Interventional

In order to assess the efficacy of the rhythm stabilization component of Health Rhythms' product in addressing sleep problems, investigators will recruit 128 outpatients over the age of 18, who are in early recovery (at least 2 weeks but no more than 6 months) from Alcohol Use Disorder (AUDIT-C score >4) and are experiencing sleep problems (ISI score >/= 10). 64 of these individuals will be randomly allocated to receive the full HealthRhythms package (sensing, trending, and stabilization) on their smartphones, while 64 will be asked to consent to sensing only. The duration of the study will be 14 weeks. The primary outcome measures of the RCT will be the ISI (Insomnia Severity Index). The investigators hypothesize that those receiving the full package will demonstrate lower levels of sleep disturbance.

NCT ID: NCT06108102 Enrolling by invitation - Stroke Clinical Trials

International Post-Stroke Epilepsy Research Repository

IPSERR
Start date: March 2024
Phase:
Study type: Observational [Patient Registry]

The International Post-Stroke Epilepsy Research Repository (IPSERR): The study aims to collate and categorize data reported by post-stroke epilepsy (PSE) researchers and lodge it within the IPSERR. Using the IPSERR database, we will conduct two individual patient data (IPD) analyses: (1) determine epilepsy, functional, and cognitive outcomes in stroke patients who develop post-stroke seizure and (2) build and validate post-stroke epilepsy prediction model and compare performance against existing models.

NCT ID: NCT06108076 Recruiting - Type 2 Diabetes Clinical Trials

Acute and Chronic Effects of Oral Ketones in Subjects With HFrEF and Diabetes

Start date: January 16, 2024
Phase: Early Phase 1
Study type: Interventional

This study will provide insight into whether cardiac function changes with oral Ketone Esters (KE) administered to patients with Type 2 Diabetes Mellitus (T2DM) and Heart failure with reduced ejection fraction (HFrEF). Plasma ketones are avidly extracted by cardiac muscle and their uptake is not dependent upon insulin or influenced by insulin resistance.

NCT ID: NCT06108063 Recruiting - Clinical trials for Knee Arthroplasty, Total

Mitigation of Arthrofibrosis After Total Knee Arthroplasty Using Losartan

Start date: March 6, 2024
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to evaluate the efficacy of Losartan use post-operatively for reducing or preventing the development of arthrofibrosis and the associated adverse impacts on clinical outcomes.

NCT ID: NCT06108050 Recruiting - Clinical trials for Advanced Solid Tumor

JZP898 Intravenous Infusion as Monotherapy and Combination With Pembrolizumab in Adults With Advanced/Metastatic Solid Tumors

Start date: November 7, 2023
Phase: Phase 1
Study type: Interventional

This Phase 1 first-in-human study will investigate the safety, tolerability, pharmacokinetics (PK), immunogenicity, and preliminary antitumor activity of JZP898 monotherapy as well as JZP898 in combination with pembrolizumab in adult participants with advanced or metastatic solid tumors.

NCT ID: NCT06108037 Completed - Communication Clinical Trials

DHL Survey on Generative AI for MyChart Messaging

Start date: October 31, 2023
Phase: N/A
Study type: Interventional

The purpose of this study is to understand how patients feel about the use of computer programs to create responses when they send electronic messages to their doctors.